Literature DB >> 2044437

Central role of sodium in hypertension in diabetic subjects.

P Weidmann1, P Ferrari.   

Abstract

The common association between diabetes mellitus and hypertension may be promoted by several mechanisms. Patients with insulin-dependent (type I) diabetes and prone to develop nephropathy often have a familial predisposition for essential hypertension, whereas normotensive healthy offspring of nondiabetic essential hypertensive parents tend to have a reduced insulin sensitivity and increased plasma insulin levels. Na+ retention occurs as a characteristic alteration in type I or non-insulin-dependent (type II) diabetes; exchangeable body Na+ (Naex) is increased by 10% on average. This abnormality develops in the uncomplicated stage of diabetes and differentiates diabetic from nondiabetic essential hypertensive subjects. Possible Na(+)- retaining mechanisms include increased glomerular filtration of glucose leading to enhanced proximal tubular Na(+)-glucose cotransport, hyperinsulinemia (which activates several tubular Na+ transporters), an extravascular shift of fluid with Na+, and, once it occurs, renal failure. The pathogenetic role of Na+ retention in diabetes-associated hypertension is supported by positive correlations between systolic or mean blood pressure and Naex and by normalization of blood pressure after removal of excess Na+ by diuretic treatment in hypertensive diabetic subjects. The latter may also have an enhanced sensitivity of blood pressure to Na+. Plasma levels of active renin, angiotensin II, aldosterone, and catecholamines are usually normal or low in metabolically stable type I or type II diabetes. However, an exaggerated vascular reactivity to norepinephrine and angiotensin II commonly occurs already at uncomplicated stages of type I or type II diabetes. This may be a manifestation of functional (i.e., intracellular electrolytes) and/or morphological (proliferation, narrowing, and stiffening) vasculopathy. Diabetes-associated Na+ retention, vasculopathy, and a presumably inherited predisposition for both diabetes and essential hypertension may represent important complementary factors favoring the frequent occurrence of hypertension in the diabetic population.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044437     DOI: 10.2337/diacare.14.3.220

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

Review 1.  Role of dietary therapies in the prevention and treatment of hypertension.

Authors:  Viresh Mohanlal; Afshin Parsa; Matthew R Weir
Journal:  Nat Rev Nephrol       Date:  2012-05-15       Impact factor: 28.314

Review 2.  Regulation of the Na+/K+-ATPase by insulin: why and how?

Authors:  G Sweeney; A Klip
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  High-fructose diet decreases catalase mRNA levels in rat tissues.

Authors:  A Cavarape; F Feletto; F Mercuri; L Quagliaro; G Daman; A Ceriello
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

4.  Magnetic resonance imaging of the kidney in type 1 (insulin-dependent) diabetes mellitus.

Authors:  R Mangili; S Sironi; G Rankel; M Makarovic; G Zerbini; A Del Maschio; G Pozza
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

5.  Hyperlipidemia, increased lipid peroxidation and changes in antioxidant enzymes, Na(+)-K(+)-ATPase in erythrocytes of type 2 diabetic patients in andhra pradesh.

Authors:  R Giri; M M Kesavulu; B K Rao; V Ramana; C A Rao
Journal:  Indian J Clin Biochem       Date:  1999-07

Review 6.  The pathogenesis of hypertension in obese subjects.

Authors:  P Weidmann; M de Courten; L Boehlen; S Shaw
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.

Authors:  I Mühlhauser; K Prange; P T Sawicki; R Bender; A Dworschak; W Schaden; M Berger
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

8.  The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.

Authors:  Masahiro Eriguchi; Ellen A Bernstein; Luciana C Veiras; Zakir Khan; Duo Yao Cao; Sebastien Fuchs; Alicia A McDonough; Jorge E Toblli; Romer A Gonzalez-Villalobos; Kenneth E Bernstein; Jorge F Giani
Journal:  J Am Soc Nephrol       Date:  2018-09-05       Impact factor: 10.121

9.  Heart rate variability and plasma norepinephrine concentration in diabetic dogs at rest.

Authors:  Prapawadee Pirintr; Winai Chansaisakorn; Monkon Trisiriroj; Sarinee Kalandakanond-Thongsong; Chollada Buranakarl
Journal:  Vet Res Commun       Date:  2012-08-02       Impact factor: 2.459

10.  Na, K-ATPase: Ubiquitous Multifunctional Transmembrane Protein and its Relevance to Various Pathophysiological Conditions.

Authors:  Mohd Suhail
Journal:  J Clin Med Res       Date:  2010-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.